Evidence map›Paper›PMID 21392437›Full record

ArticleEmerging infectious diseases2011

Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007.

Christof J Majoor, Cecile Magis-Escurra, Jakko van Ingen, Martin J Boeree, Dick van Soolingen

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Emerging infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Genetic diversity and antibiotic resistance ofFrontiers in cellular and infection microbiology · 2025
    Article
  8. LaryngealCase reports in otolaryngology · 2025
    Article
  9. Emergence ofFrontiers in public health · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. DisseminatedClinical case reports · 2021
    Article
  17. Article
  18. Article
  19. Global Distribution and Evolution ofFrontiers in microbiology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Christof J MajoorDepartment of Pulmonology, Academic Medical Center, Amsterdam, The Netherlands. c.j.majoor@amc.uva.nl
Cecile Magis-Escurra
Jakko van Ingen
Martin J Boeree
Dick van Soolingen
Academic Medical Center · NLRadboud University Medical Center · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the Netherlands, 1.4% of tuberculosis (TB) cases are caused by Mycobacterium bovis. After we admitted 3 patients with M. bovis infections to our reference hospital, we conducted a retrospective analysis of all M. bovis disease in the Netherlands during 1993-2007. We analyzed data from 231 patients for clinical, demographic, treatment, and outcome characteristics and for risk factors. Most patients were native Dutch (n = 138; 59.7%) or Moroccan (n = 54; 23.4%). Disease was mainly extrapulmonary (n = 136; 58.9%). Although 95 patients had pulmonary disease, person-to-person transmission did not occur, as shown by structural DNA fingerprinting analysis. Lymph node TB was more likely to develop in women (p<0.0001), whereas pulmonary M. bovis disease developed more frequently in men (p<0.0001). Diagnosis was accurate but delayed and led to inadequate treatment in 26% of the cases. Proportion of deaths from M. bovis disease was higher than that for M. tuberculosis disease.

Indexed as

AdolescentAdultAgedAged, 80 and overAntitubercular AgentsChildChild, PreschoolDNA FingerprintingEmigrants and ImmigrantsFemaleHumansInfantInfant, NewbornMaleMiddle AgedMycobacterium bovisAntitubercular Agents

Identifiers

PMID21392437
PMCPMC3166011
OpenAlexW2041505312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.